WSFS
NVCR icon

Wilmington Savings Fund Society’s NovoCure NVCR Stock Holding History

Wilmington Savings Fund Society’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.03K Hold
200
– – ﹤0.01% 1316
2026
Q1 		$2.18K Hold
200
– – ﹤0.01% 1344
2025
Q4 		$2.59K Hold
200
– – ﹤0.01% 1299
2025
Q3 		$2.58K Sell
200
-161
-45% -$2.15K ﹤0.01% 1292
2025
Q2 		$6.43K Hold
361
– – ﹤0.01% 1720
2025
Q1 		$6.43K Hold
361
– – ﹤0.01% 1735
2024
Q4 		$10.8K Hold
361
– – ﹤0.01% 1643
2024
Q3 		$5.64K Buy
+361
New +$6.55K ﹤0.01% 1760

Other funds holding NVCR

BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Wilmington Savings Fund Society's NVCR Position: Q2 2026 in Review

Wilmington Savings Fund Society held its NovoCure (NVCR) position steady in Q2 2026 at 200 shares worth $3.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1316.

Wilmington Savings Fund Society first reported a position in NVCR in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.8K in Q4 2024. 37 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Wilmington Savings Fund Society held 200 shares of NovoCure worth $3.03K as of Q2 2026.
  • Wilmington Savings Fund Society left its NovoCure share count unchanged in Q2 2026.
  • NovoCure made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1316 holding.
  • Wilmington Savings Fund Society first reported a position in NovoCure in Q3 2024 and has held it in 8 quarters since.
  • Wilmington Savings Fund Society's NovoCure position peaked at $10.8K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.